State Street Portfolio holdings
State Street is a bank holding company, with roots going back to Union Bank, chartered in 1792, that both manages investments and holds securities for other investors. The company takes its name from State Street in Boston, and in 1924 it began safekeeping the holdings of the country's first mutual fund, the Massachusetts Investors Trust. In 1993 it created the SPDR S&P 500 Trust, the first exchange-traded fund. State Street formed its asset management arm, State Street Global Advisors, in 1994, and in 1999 exited retail and commercial banking by selling those businesses to Citizens Financial Group. Its asset management division serves corporations, mutual funds, insurance companies and other institutional investors, running both index-tracking and actively managed strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.28B |
| 2 |
Apple
AAPL
|
+$2.37B |
| 3 |
Microsoft
MSFT
|
+$2.34B |
| 4 |
Vivmark Residential
VMRK
|
+$1.63B |
| 5 |
Broadcom
AVGO
|
+$1.56B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Electronic Arts
EA
|
+$2.88B |
| 2 |
AvalonBay Communities
AVB
|
+$1.73B |
| 3 |
Marathon Petroleum
MPC
|
+$668M |
| 4 |
Phillips 66
PSX
|
+$643M |
| 5 |
Valero Energy
VLO
|
+$566M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.16% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.03% |
| 4 | Industrials | 9.3% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1376
iShares Core S&P Small-Cap ETF
IJR
$106B
| $114M | ﹤0.01% |
836,836
+39,412
| +5% | +$5.7M |
2018 Q4
31 quarters
|
|
1377
Kinetik
KNTK
$4.42B
| $113M | ﹤0.01% |
2,258,255
+259,499
| +13% | +$13.4M |
2021 Q2
21 quarters
|
|
1378
Ultragenyx Pharmaceutical
RARE
$1.64B
| $113M | ﹤0.01% |
7,538,078
+1,379,312
| +22% | +$33.1M |
2014 Q1
50 quarters
|
|
1379
Loar Holdings
LOAR
$7.01B
| $113M | ﹤0.01% |
1,839,316
-497,482
| -21% | -$35.1M |
2024 Q2
9 quarters
|
|
1380
ManpowerGroup
MAN
$2.17B
| $113M | ﹤0.01% |
2,030,912
-3,493
| -0.2% | -$189K |
2013 Q2
53 quarters
|
|
1381
Celldex Therapeutics
CLDX
$2.26B
| $113M | ﹤0.01% |
3,478,549
-421,878
| -11% | -$16.1M |
2020 Q3
24 quarters
|
|
1382
PVH
PVH
$4.31B
| $112M | ﹤0.01% |
1,510,760
+28,369
| +2% | +$2.21M |
2013 Q2
53 quarters
|
|
1383
DNOW Inc
DNOW
$2.51B
| $111M | ﹤0.01% |
7,189,785
-89,829
| -1% | -$1.35M |
2014 Q2
49 quarters
|
|
1384
Blue Owl Capital
OWL
$6.75B
| $111M | ﹤0.01% |
12,239,199
+42,224
| +0.3% | +$444K |
2021 Q3
20 quarters
|
|
1385
WD-40
WDFC
$2.99B
| $111M | ﹤0.01% |
550,602
+1,403
| +0.3% | +$312K |
2013 Q2
53 quarters
|
|
1386
iShares Core S&P Mid-Cap ETF
IJH
$124B
| $111M | ﹤0.01% |
1,545,570
+151,233
| +11% | +$11.4M |
2018 Q4
31 quarters
|
|
1387
Cushman & Wakefield Ltd
CWK
$3.12B
| $111M | ﹤0.01% |
9,408,779
-159,452
| -2% | -$2.14M |
2018 Q3
32 quarters
|
|
1388
United Natural Foods
UNFI
$2.92B
| $111M | ﹤0.01% |
2,469,580
+10,771
| +0.4% | +$508K |
2013 Q2
53 quarters
|
|
1389
DELISTED
Supernus Pharmaceuticals
SUPN
| $111M | ﹤0.01% |
2,569,141
+109,313
| +4% | +$4.98M |
2013 Q2
53 quarters
|
|
1390
John Wiley & Sons Class A
WLY
$2.54B
| $111M | ﹤0.01% |
2,314,918
+51,064
| +2% | +$2.59M |
2013 Q2
53 quarters
|
|
1391
Kanzhun
BZ
$5.67B
| $110M | ﹤0.01% |
7,211,336
+164,290
| +2% | +$2.56M |
2021 Q4
19 quarters
|
|
1392
Beta Technologies Inc
BETA
$5.48B
| $110M | ﹤0.01% |
4,982,835
+2,406,391
| +93% | +$50.5M |
2025 Q4
3 quarters
|
|
1393
Itaú Unibanco
ITUB
$83B
| $110M | ﹤0.01% |
12,876,279
+142,176
| +1% | +$1.15M |
2013 Q2
53 quarters
|
|
1394
Knife River
KNF
$3.2B
| $109M | ﹤0.01% |
2,169,782
+14,929
| +0.7% | +$1.01M |
2023 Q2
13 quarters
|
|
1395
Boise Cascade
BCC
$2.35B
| $109M | ﹤0.01% |
1,468,927
-28,297
| -2% | -$2.21M |
2013 Q2
53 quarters
|
|
1396
Agios Pharmaceuticals
AGIO
$1.89B
| $109M | ﹤0.01% |
3,264,652
-268,981
| -8% | -$9.41M |
2013 Q3
52 quarters
|
|
1397
Vanguard Morningstar Small-Cap ETF
VB
$79B
| $109M | ﹤0.01% |
381,428
-80,909
| -18% | -$24.1M |
2021 Q1
22 quarters
|
|
1398
Artisan Partners
APAM
$2.73B
| $108M | ﹤0.01% |
2,990,343
+41,694
| +1% | +$1.65M |
2013 Q2
53 quarters
|
|
1399
Protolabs
PRLB
$1.61B
| $108M | ﹤0.01% |
1,135,014
-3,448
| -0.3% | -$283K |
2013 Q2
53 quarters
|
|
1400
TeraWulf
WULF
$6.33B
| $107M | ﹤0.01% |
7,257,484
+333,813
| +5% | +$5.84M |
2022 Q1
18 quarters
|
|
Similar funds
State Street's Q3 2026 Portfolio in Review
As of Q3 2026, State Street held 4,412 positions worth $3.44T, up 1.5% from $3.38T the previous quarter. Its ten largest holdings account for 32% of the portfolio.
State Street's Q3 2026 filing shows 131 new, 2,095 increased, 1,596 reduced and 103 closed positions. Its largest new stake was Mobility Global Inc: 10,220,400 shares worth $175M. The largest sale was Electronic Arts, an estimated $2.88B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.
- State Street's largest Q3 2026 buy was Mobility Global Inc: 10,220,400 shares worth $175M.
- State Street added most to NVIDIA in Q3 2026, an estimated $3.28B increase.
- State Street's biggest Q3 2026 reduction was Marathon Petroleum, cutting an estimated $668M.
- State Street fully exited Electronic Arts in Q3 2026, selling an estimated $2.88B.
- State Street's ten largest holdings make up 32% of its $3.44T portfolio in Q3 2026.
- State Street opened 131 new positions and closed 103 in Q3 2026.
- State Street's portfolio value rose 1.5% quarter-over-quarter to $3.44T.
Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.